M. Mancini

754 total citations
10 papers, 645 citations indexed

About

M. Mancini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, M. Mancini has authored 10 papers receiving a total of 645 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in M. Mancini's work include Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Colorectal and Anal Carcinomas (2 papers). M. Mancini is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Colorectal and Anal Carcinomas (2 papers). M. Mancini collaborates with scholars based in Italy, United States and Spain. M. Mancini's co-authors include Michael A. Mancini, Christopher J. Cummings, Kavita Patel, Marco Marcelli, George Demartino, Nancy L. Weigel, Henry P. Adams, David L. Stenoien, Orietta Gandini and Flavia Longo and has published in prestigious journals such as Journal of Clinical Oncology, Scientific Reports and Human Molecular Genetics.

In The Last Decade

M. Mancini

10 papers receiving 636 citations

Peers

M. Mancini

CMN

ONCOL

PRM

Glenn Pacheco United States

Sophie Kusy France

Maria Grazia Rizzetti Italy

Sandra Bondong Germany

Jiaxin Fan United States

Barbara Costa Germany

Adele G. Woolley New Zealand

Miguel Sáinz‐Jaspeado Spain

Sean Tsao United States

Alice Bartolini Italy

Glenn Pacheco United States

M. Mancini

408 ×1.1

230 ×0.9

CMN

252 ×1.1

ONCOL

67 ×0.5

PRM

98 ×0.8

Citations per year, relative to M. Mancini M. Mancini (= 1×) peers Glenn Pacheco

Countries citing papers authored by M. Mancini

Since Specialization

Citations

This map shows the geographic impact of M. Mancini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Mancini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Mancini more than expected).

Fields of papers citing papers by M. Mancini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Mancini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Mancini. The network helps show where M. Mancini may publish in the future.

Co-authorship network of co-authors of M. Mancini

This figure shows the co-authorship network connecting the top 25 collaborators of M. Mancini. A scholar is included among the top collaborators of M. Mancini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Mancini. M. Mancini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Moreno‐Loshuertos, Raquel, Christina Y. Yim, Tyler D. Ames, et al.. (2024). Cancer cell-selective induction of mitochondrial stress and immunogenic cell death by PT-112 in human prostate cell lines. Journal of Translational Medicine. 22(1). 927–927. 4 indexed citations

Felice, Francesca De, Giancarlo D’Ambrosio, Daniela Musio, et al.. (2018). Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery in locally advanced rectal cancer: preliminary results of a phase II study. Oncotarget. 9(72). 33702–33709. 5 indexed citations

Procopio, Giuseppe, Michele Prisciandaro, Roberto Iacovelli, et al.. (2017). Safety and efficacy of Cabozantinib for metastatic renal cell carcinoma (mRCC): real world data from an Italian Expanded Access Program (EAP). Annals of Oncology. 28. v319–v320. 1 indexed citations

Rossini, Daniele, Roberto Moretto, Chiara Cremolini, et al.. (2017). Treatments (tx) after progression to first-line FOLFOXIRI plus bevacizumab (bev) in metastatic colorectal cancer (mCRC) patients (pts): A pooled analysis of TRIBE and MOMA studies by GONO group.. Journal of Clinical Oncology. 35(15_suppl). 3542–3542. 3 indexed citations

Cortesi, Enrico, Gianluca Masi, M. Mancini, et al.. (2016). P-158 Radioembolization (SIRT) as a Consolidation Treatment in Colorectal Liver Metastases after First Line Chemotherapy: Efficacy Safety. Annals of Oncology. 27. ii47–ii47. 1 indexed citations

Nicolazzo, Chiara, Cristina Raimondi, M. Mancini, et al.. (2016). Monitoring PD-L1 positive circulating tumor cells in non-small cell lung cancer patients treated with the PD-1 inhibitor Nivolumab. Scientific Reports. 6(1). 31726–31726. 239 indexed citations

Grossi, Francesco, Lucio Crinò, A. Misino, et al.. (2016). Efficacy and safety of nivolumab in elderly patients (pts) with advanced squamous non small cell lung cancer (Sq-NSCLC) participating in the expanded access programme (EAP) in Italy. Annals of Oncology. 27. vi369–vi369. 5 indexed citations

Pascucci, Luisa, Cecilia Dall’Aglio, Francesca Mercati, et al.. (2015). Horse adipose-derived mesenchymal stromal cells constitutively produce membrane vesicles: a morphological study.. PubMed. 30(5). 549–57. 11 indexed citations

Falcone, Alfredo, Gianluca Masi, Enrico Vasile, et al.. (2009). 6085 FOLFOXIRI (irinotecan, oxaliplatin, infusional 5FU/LV) vs FOLFIRI as first-line treatment of metastatic colorectal cancer (mCRC): updated results after 5 years follow up and risk-stratified analysis. European Journal of Cancer Supplements. 7(2). 348–348. 3 indexed citations

10.

Stenoien, David L., Christopher J. Cummings, Henry P. Adams, et al.. (1999). Polyglutamine-Expanded Androgen Receptors Form Aggregates That Sequester Heat Shock Proteins, Proteasome Components and SRC-1, and Are Suppressed by the HDJ-2 Chaperone. Human Molecular Genetics. 8(5). 731–741. 373 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact